🚨 BREAKING Scientists may have just cracked the code... on Alzheimer's and Parkinson's — WITH ONE PILL. A drug called Buntanetap was just published in a peer-reviewed journal with Phase 3 data. Phase 3 means that we are on the verge of FDA approval. It targets the ROOT CAUSE of both diseases simultaneously. Here's what you need to know 🧵👇 #Alzheimers #Parkinsonsshow more

🚨 BREAKING: Most people don't know that certain diseases... dramatically raise their risk of developing Parkinson's. This isn't speculation. It's peer-reviewed science involving millions of patients. Some of these conditions are treatable, and treating them may lower your risk. Here's what the research actually says 🧵👇show more

🚨 BREAKING: Scientists just delivered a gene into human... brains that could PREVENT Alzheimer's in the highest-risk people on Earth. Phase 1 trial. 15 patients. Zero serious side effects. And it WORKED. Thread 🧵👇show more

BREAKING: Scientists may have found the first treatment that... actually slows Parkinson's disease — and it costs $0. It's not a drug. It's not a surgery. It's exercise. But not just any exercise. The TYPE and INTENSITY matter enormously. Here's what the clinical trials actually show 🧵show more

🚨 BREAKING Scientists just cracked one of cancer's hardest... problems. A new therapy called KIR-CAR just showed — for the first time in humans — that it can fight solid tumors that NO approved CAR-T therapy has ever beaten. Zero serious side effects. Tumors shrinking. Here's what happened 🧵show more

The U.S. FDA CDER just approved a new treatment... for Hunter Syndrome. I discuss what Hunter Syndrome is, the data the approval was based on, the post marketing requirement and what this means for families who have children with the disease. For more info👇show more

Eli Lilly, the maker of Zepbound and Mounjaro, said... its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the drug for approval from the Food and Drug Administration. CBS News’ Jonathan LaPook, M.D explains.show more

Today was my 1st day a physical therapy and... it was one of the toughest because it’s the range of motion phase and having to deal with some swelling and healing going on in the knee this is a very important phase and after that comes the strengthening phase, or weight training!show more

So the leaders of Burkina Faso, Mali and Niger... Republic finally exposed the Nigerian politicians behind Christian genocide and terrorism in Nigeria, naming names and the Nigerian media went completely silent. You may have already seen this video but watch again and share it video like your life depends on it. But just to let you know, this just phase 1. Phase 2 is coming, there will also be phase 3. But don’t pray to see the phase 4. Those who follow me on YouTube can now see clearly that I don’t drink from the same tap as many. I told you what to expect in 2027. The Sahel leaders say Nigeria is a cancer, and you know what that means. Watch and share 👇🏾🔥‼️show more

We introduce Tagger Phase 2, bringing manual #data labeling... and #data review into the #DeCorp ecosystem. With this iteration, we have completed the final components necessary for a fully integrated and decentralized cycle: 1) Data processing from scratch 2) Peer-to-peer data validation 3) Automated pre-training of AI copilot models 4) Quasi-autonomous active learning It is not long now before you may directly engage with this unprecedented and comprehensive system. See you soon.show more

NIH Director Dr. Jay Bhattacharya says one peer-reviewed paper... doesn’t mean the science is settled. “There’s a sort of glamour to a peer-reviewed published paper, especially in a top journal.” “You read the paper, you want to believe it’s true… but that’s not enough.” “Scientists get enamored with our own ideas.” “One paper isn’t enough.” MAHA Institute Jay Bhattacharya, MD, PhDshow more

BREAKING: Scientists just gave two old, cheap drugs to... MS patients — a hay fever pill and a diabetes tablet — and measured something no drug has ever shown before. Signs of actual nerve repair. Not slowing the attack. REPAIRING the damage. Here's the science behind it 🧵show more

🚨 John Solomon says that, based on what he’s... seen, we are in Phase 2 of 5—just the beginning—as we continue to look into blue areas in states pertaining to election fraud. “This is phase two—where elections are administered the way the law says they’re supposed to be, and as a result the FBI may come in and prosecute people.”show more

Class is officially in session 📚 Detroit, Hamilton, Las... Vegas and San Jose are entering the league, and now the roster-building process begins! Here's a quick breakdown of what you need to know about the 6-phase Expansion Player Distribution Process ahead of Phase One opening tomorrow.show more

Yesterday, Trump announced Israel and Hamas have “signed off... on the first phase” of a deal to end the war in Gaza. Dasha Burns was on the phone with the president late last night, here's what he said about the agreement 👇 🎧 Listen on #playbookpod:show more

We are proud to announce that Phase Two of... the Aleo Testnet was a huge success 🎉 Aleo is getting closer to Mainnet, and we invite you to be a part of the journey. Here's all that Aleo accomplished and what to expect next👇show more

BREAKING: Scientists just ran the first-ever clinical trial of... creatine in Alzheimer’s patients. Brain creatine went up. Memory and thinking improved. But the same supplement FAILED a 5-year, 1,741-patient Parkinson’s trial in 2015. What changed? What does this mean for brain energy? A thread on the most fascinating story in brain energy research right now. 🧵🧪 #Alzheimers #Parkinsons #Creatineshow more

Dr. Peter McCullough testifies in U.S. Senate and the... evidence is jaw dropping. The mRNA injections should have had a black box warning for "death", and he presents the largest peer reviewed autopsy series in the World. Dr. McCullough: "When a product definitely results in death [there must be a] black box warning on the product immediately [they] still don't have the word "death" on the package insert" . Sen. Ron Johnson: "Do you have any science to back up your opinion?". Dr. McCullough: "The best data are autopsies. So in the largest autopsy series published to date, I know because I'm the senior author ... of all the deaths we examined, and we re-reviewed them, we had an adjudication committee, we had ways of arbitration, deciding on did the vaccine cause death ... the answer is ... of these cases that came in for autopsy after vaccination, 73.9% of individuals, it was determined that the vaccine was the cause of death".show more

🚨 The Paxil scandal is an astonishing example of... how drug data can be hidden and spun—and then sold to kids. “In the late 90s, the manufacturer GlaxoSmithKline or GSK did a series of trials and found that the drug was no better than placebo. …There was an email that was sent to staff where GSK said that [it] would be commercially unacceptable to disclose the poor efficacy data of this drug. So instead of telling the truth, they hired a PR firm to write the medical journal for them, to ghostwrite the article and put a positive spin on it, and then that was submitted to the journal, and it was published in 2001. And it wasn't long before the regulators in the US and also in Europe discovered that the drug actually was increasing the risk of suicidal ideation. It was doing the exact opposite of what the drug was meant to do. And so they put out a warning saying that this drug showed no efficacy in children and adolescents, but the drug continued to be marketed off-label…because the prominent journal had published this peer-reviewed paper. GSK purchased thousands of pre-prints and sent them out to all their representatives, and then they went to doctors, giving free samples, saying this drug is safe and effective for children. And I think within a time span of three years, GSK made over a billion dollars in sales from a drug that had never proven to be safe or effective in children and adolescents.” -Investigative journalist Maryanne Demasi, PhDshow more

"Why does our FDA still incentivize all of this... innovation to go to China?" Tweets from Zach Weinberg: "You can go to China, you can run a first-in-human study in a Chinese population at a Chinese hospital, you get your result, and then you can take that result back to America and skip the line." "I don't have to redo that Phase 1 and Phase 2 in a Western nation. I can use my Chinese data to open a Phase 3 study here and go for an approval." "Think about the incentive structure for a US biotech. You have to go to China. There is no alternative path because you've got competition on the other side who is racing ahead with infrastructure that you can't use." "We don't inspect, we don't audit, we don't send inspectors to these clinical trial sites. We have no idea what's actually going on." The Hill & Valley Forum 2026 The Hill & Valley Forumshow more